Med
- ISSN: 2666-6340
Next planned ship date: December 11, 2023
- 5 Year impact factor: 17
- Impact factor: 17
Med is a flagship clinical and translational research monthly journal published by Cell Press, the global publisher of trusted and authoritative science journals including Cell,… Read more
Subscription options
Next planned ship date:
December 11, 2023
Institutional subscription on ScienceDirect
Request a sales quoteAging and health-span interventions: sarcopenia; senescence and senolytic treatments; dietary interventions; hormonal disorders
Biomedical engineering – new device optimization and diagnostic tools
Cancer: immuno-oncology; tumor evolution and cancer genetics; surgery and therapeutic modalities
Cardiovascular and metabolic disease: heart disease; diabetes; obesity; NAFLD/NASH
Genetics and cell-based therapies: medical genomics; CRISPR-based; RNAi; stem cells; organoids; transplantation
Health economics and public policy: global challenges; health access; public health interventions; clinical practices
Human microbiome: mechanistic studies of the human microbiomes impact on disease
Immunology: allergy and inflammation; autoimmunity; innate immunity; graft-versus host disease; vaccinology
Infectious diseases: HIV/AIDS; SARS; ebola; other bacterial, viral, fungal, or parasitic infections; infectious diseases epidemiology; antimicrobials and resistance
Neurology: Alzheimers disease; dementia; cognitive dysfunctions; brain-vascular dysfunction; Parkinsons and movement disorders; amyotrophic lateral sclerosis; depression; neuroengineering therapies
Visit the Cell Press website for more information about Med - http://www.cell.com/med/home- ISSN: 2666-6340
- Volume 1
- Issue 12
- 5 Year impact factor: 17
- Impact factor: 17